The Weight Regain Problem Nobody Warns You About When Stopping GLP-1 Drugs
People regain weight faster after stopping GLP-1 medications than other weight loss methods—averaging 2 pounds monthly.
52 articles
People regain weight faster after stopping GLP-1 medications than other weight loss methods—averaging 2 pounds monthly.
Intermittent fasting doesn't beat regular calorie restriction for weight loss, but it may help some people stick to their goals.
Research shows most people who lose weight quickly regain it—and sometimes more. Here's what science says about sustainable weight loss versus crash diets.
A comprehensive Cochrane review of 22 studies shows intermittent fasting produces similar weight loss to regular dieting—but experts say the findings may be misleading.
Federal programs are expanding GLP-1 access, but 13 states have cut or restricted coverage due to soaring costs—creating a confusing gap between policy and reality.
A new once-daily oral weight loss pill shows promise as an easier alternative to injections, with FDA decision expected soon.
A new clinical framework reveals that metabolic dysfunction-associated fatty liver disease affects 30% of adults worldwide and requires personalized, whole-body care—not just liver treatment.
New research reveals that gaining back weight after losing it through diet and exercise triggers liver inflammation—even without advanced liver disease.
The WHO conditionally endorses GLP-1 drugs for long-term obesity treatment, but warns that production limits and cost could leave 90% of patients without access.
A major analysis of 28 studies shows tirzepatide beats semaglutide by 6% in weight loss and better controls blood sugar.
New research reveals your cells strategically select which fats to burn based on energy efficiency, not random metabolism.
A major study found that genetic testing doesn't improve weight loss results compared to standard diet advice—but the findings challenge a growing wellness trend.
New research shows pairing calorie reduction with resistance training produces dramatically better weight loss and metabolic improvements than trying either strategy separately.
Between 20-30% of bariatric surgery patients regain weight. Researchers are comparing single and dual-action medications to help—but success requires more than pills alone.
Berberine supplements are going viral as a natural weight loss alternative, but research shows modest results of 2-4 pounds over months—far less than prescription GLP-1 drugs.
New research reveals bariatric surgery's lasting weight loss isn't just about restriction; it fundamentally alters appetite-regulating hormones like GLP-1.
Tiny molecular proteins called sirtuins control how your body stores and burns fat. Here's how to activate them naturally.
The American Diabetes Association's 2026 guidelines show personalized weight management approaches work better than universal solutions.
While Novo Nordisk's Wegovy dominates the market, a wave of biotech companies are developing next-generation obesity treatments that could offer new options for weight management.
Real-world study of 51,085 patients shows bariatric surgery delivers 58-pound average weight loss versus 12 pounds with GLP-1 drugs after two years.
New research reveals how oxytocin levels drop during ketogenic diets—and why your baseline levels might forecast how much weight you'll actually lose.
A new clinic system called PATHWEIGH eliminated population weight gain across 56 primary care clinics by letting patients request dedicated weight visits.
UK experts warn that strict NHS rules for new obesity drugs could create a two-tier system where wealth determines access to treatment.
A study found diet pill users face higher eating disorder risks within three years, while these medications can make natural weight loss harder long-term.
New research reveals that seeing a weight management specialist alongside your diabetes doctor can dramatically boost your success with GLP-1 medications like Ozempic.
New research shows people regain weight nearly four times faster after stopping GLP-1 drugs like Ozempic compared to traditional diet methods.
New study of 226 patients reveals most people taking GLP-1 drugs like Ozempic stay mentally stable, but 9% develop new depression or anxiety.
New research reveals that drinking tea, especially green tea, can significantly reduce heart disease risk and support weight management—but not all teas are equal.
While GLP-1 drugs like Ozempic work amazingly well for weight loss, they're causing unexpected muscle loss that could undermine long-term health.
Harvard researchers discovered gut bacteria produce molecules that travel to the liver and control energy use, opening new treatment paths for obesity and diabetes.
Scientists identified 44 blood markers that predict diabetes risk 5 times better than traditional methods, potentially revolutionizing personalized weight management.
Your gynecologist is qualified to prescribe Ozempic for weight management, especially if weight affects your hormones, fertility, or health. Here's how it works.
Poor sleep disrupts hunger hormones and metabolism, making weight loss nearly impossible even with perfect diet and exercise.
New research reveals how the balance of carbs to fats in your diet triggers specific metabolic changes—even when weight stays the same.
New research reveals that losing weight during midlife may cause temporary brain inflammation, even while improving metabolism.
New research reveals that traditional BMI calculations miss crucial metabolic health markers, with scientists developing a more accurate measure.
New research reveals a metabolome-informed obesity metric that captures health risks BMI misses, explaining 52% of weight variance and better predicting disease.
Natural weight loss methods like green tea and spicy foods create lasting results by boosting metabolism and reducing cravings without the rebound effect.
Leading endocrinologists explain how simple daily habits—not genetics—control your metabolic rate and weight management success.
New oral weight loss medications and breakthrough treatments are changing how doctors approach obesity, with some showing 12% weight loss in just 26 weeks.
New expert insights reveal simple daily changes can dramatically improve your metabolic health—no extreme diets required.
New expert insights reveal how sleep, stress, and insulin create a hidden weight-gain cycle—plus the surprising truth about weight loss injections.
New research reveals 1 in 4 adults globally may be eligible for GLP-1 obesity treatments, sparking a major shift in how doctors approach weight management.
Older adults who swapped ultra-processed foods for whole ingredients lost weight and improved metabolism without calorie counting—even with two different diet styles.
New weight loss medications work by mimicking your body's natural fullness hormone, leading to 15-20% weight loss in clinical trials.
New research reveals that traditional BMI measurements miss 52% of metabolic dysfunction, meaning you could have a healthy weight but unhealthy metabolism.
A new obesity definition that includes waist measurements alongside BMI could reclassify nearly 70% of Americans as obese.
The first GLP-1 weight loss pill hits the market in January, offering a needle-free alternative that could make treatment accessible to millions more Americans.
New research reveals combining exercise with calorie restriction doubles insulin sensitivity improvements compared to diet alone.
New obesity drugs are delivering unprecedented weight loss results, with some patients losing nearly 30% of their body weight—rivaling surgical outcomes.